4.3 Article

How to Determine Unresectability in Hilar Cholangiocarcinoma

Related references

Note: Only part of the references are listed.
Review Oncology

Neoadjuvant Therapy Regimens for Hilar Cholangiocarcinoma Before Liver Transplant

Samuel J. Keltner et al.

Summary: The use of neoadjuvant radiation therapy for patients with unresectable hilar cholangiocarcinoma before liver transplantation varies greatly. Different radiation doses and fractionation schemes are utilized, with cumulative doses ranging from 40 to 110 Gy (EQD2). Further studies are needed to evaluate the efficacy and toxicity of these different approaches and provide better guidance for best practices.

AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS (2023)

Article Oncology

Role of Intraoperative Assessment of Proximal Bile Duct Margin Status and Additional Resection of Perihilar Cholangiocarcinoma: Can Local Clearance Trump Tumor Biology? A Retrospective Cohort Study

Fumihiro Kawano et al.

Summary: The clinical implications of the proximal bile duct margin status in resection of perihilar cholangiocarcinoma (PHCC) were evaluated in this study. The study found that an initial positive proximal hepatic duct margin was associated with poor long-term outcomes for patients with resectable PHCC. Additional resection after achieving a negative margin had minimal impact on survival.

ANNALS OF SURGICAL ONCOLOGY (2023)

Article Gastroenterology & Hepatology

AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma

Christopher L. Bowlus et al.

HEPATOLOGY (2023)

Review Surgery

Guidelines for Perioperative Care for Liver Surgery: Enhanced Recovery After Surgery (ERAS) Society Recommendations 2022

Gaetan-Romain Joliat et al.

Summary: The present study aimed to update the ERAS guidelines in liver surgery using a modified Delphi method based on a systematic review of the literature. A total of 25 recommendation items were elaborated, which obtained consensus from international experts. These guidelines allow standardization of the perioperative management of patients undergoing liver surgery.

WORLD JOURNAL OF SURGERY (2023)

Review Surgery

Postoperative mortality after liver resection for hepatocellular carcinoma-A systematic review. Metanalysis and metaregression of studies published in the last 5 years

Bhavin Vasavada et al.

Summary: The study aimed to analyze the 90-day mortality after liver resection for hepatocellular carcinoma, with a weighted mortality rate of 4.2%. Factors like major hepatectomy and open surgery were found to be associated with heterogeneity and mortality.

SURGICAL PRACTICE (2022)

Review Oncology

Progress in Radiotherapy for Cholangiocarcinoma

Ningyu Wang et al.

Summary: This article reviews recent clinical studies on cholangiocarcinoma, including the timing of radiotherapy, delineation of the target area, and dose of radiotherapy. Furthermore, it summarizes the development of large fraction radiotherapy, immunotherapy, and targeted drugs combined with radiotherapy in cholangiocarcinoma.

FRONTIERS IN ONCOLOGY (2022)

Review Oncology

Does Caudate Resection Improve Outcomes of Patients Undergoing Curative Resection for Perihilar Cholangiocarcinoma? A Systematic Review and Meta-Analysis

Richard W. D. Gilbert et al.

Summary: This review examines the impact of caudate lobe resection in perihilar cholangiocarcinoma and supports the routine use of caudate lobectomy in the surgical management of this condition.

ANNALS OF SURGICAL ONCOLOGY (2022)

Review Gastroenterology & Hepatology

Cholangiocarcinoma: a review of the literature and future directions in therapy

Ritika Halder et al.

Summary: Cholangiocarcinomas are rare cancers that usually require surgical resection and chemotherapy. Efforts to improve survival rates include offering neoadjuvant therapy, but most patients are not diagnosed at an early stage. Ongoing research is exploring targeted therapies through various mutational pathways.

HEPATOBILIARY SURGERY AND NUTRITION (2022)

Article Oncology

The Clinical Management of Cholangiocarcinoma in the United States and Europe: A Comprehensive and Evidence-Based Comparison of Guidelines

Zhi Ven Fong et al.

Summary: Guidelines for clinical management of cholangiocarcinoma in the US and Europe show discordance in recommendations for biopsy, fluorodeoxyglucose positron emission tomography scans, and preoperative biliary drainage. Although trials like BILCAP and ABC-02 have provided strong evidence for systemic therapy, the guidelines have not set them as standard care, and future iterations may focus on diagnostic biomarkers and novel therapies.

ANNALS OF SURGICAL ONCOLOGY (2021)

Review Oncology

Vascular Resection in Perihilar Cholangiocarcinoma

Alejandro Serrablo et al.

Summary: Perihilar cholangiocarcinoma with vascular involvement presents challenges in treatment options, with varying outcomes in morbidity, mortality, and overall survival rates worldwide. Different approaches, including extended resections and neoadjuvant therapy, are considered to achieve R0 status or potential cure. Despite advances in surgical techniques, there remains variability in outcomes, with positive margins still observed in a significant number of cases.

CANCERS (2021)

Review Gastroenterology & Hepatology

The effect of prehabilitation on postoperative complications and postoperative hospital stay in hepatopancreatobiliary surgery a systematic review

Maxime Dewulf et al.

Summary: This study reviewed the effects of prehabilitation in hepatopancreatobiliary surgery and found a trend towards fewer complications and shorter hospital stay in the prehabilitation group. However, current evidence does not demonstrate a statistically significant difference between groups.
Article Surgery

Preoperative portal vein or portal and hepatic vein embolization: DRAGON collaborative group analysis

J. Heil et al.

Summary: The study found that simultaneous embolization of portal and hepatic veins (PVE/HVE) can accelerate future liver remnant (FLR) hypertrophy and improve resectability, with better outcomes compared to portal vein embolization (PVE) alone.

BRITISH JOURNAL OF SURGERY (2021)

Article Oncology

The impact of peritoneal lavage cytology in biliary tract cancer (KHBO1701): Kansai Hepato-Biliary Oncology Group

Satoshi Matsukuma et al.

Summary: The positive status of peritoneal lavage cytology may moderately affect the survival of patients with biliary tract cancers, but recurrence rates and recurrence-free survival were similar between cytology-negative and cytology-positive groups.

CANCER REPORTS (2021)

Article Oncology

Perihilar cholangiocarcinoma: A different concept for radical resection

Yury Alexeevich Kovalenko et al.

SURGICAL ONCOLOGY-OXFORD (2020)

Review Anesthesiology

Preoperative Evaluation of the Frail Patient

Lolita S. Nidadavolu et al.

ANESTHESIA AND ANALGESIA (2020)

Review Surgery

Modern work-up and extended resection in perihilar cholangiocarcinoma: the AMC experience

F. Rassam et al.

LANGENBECKS ARCHIVES OF SURGERY (2018)

Review Gastroenterology & Hepatology

Surgical management of hilar cholangiocarcinoma at Memorial Sloan Kettering Cancer Center

Michael E. Lidsky et al.

ANNALS OF GASTROENTEROLOGICAL SURGERY (2018)

Review Radiology, Nuclear Medicine & Medical Imaging

Imaging of Perihilar Cholangiocarcinoma

Marc Rudi Engelbrecht et al.

AMERICAN JOURNAL OF ROENTGENOLOGY (2015)

Article Surgery

Recurrence Rate and Pattern of Perihilar Cholangiocarcinoma after Curative Intent Resection

Bas Groot Koerkamp et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2015)

Article Gastroenterology & Hepatology

Hilar Cholangiocarcinoma: expert consensus statement

John C. Mansour et al.

Review Cardiac & Cardiovascular Systems

Portal Vein Embolization Before Liver Resection: A Systematic Review

K. P. van Lienden et al.

CARDIOVASCULAR AND INTERVENTIONAL RADIOLOGY (2013)

Review Gastroenterology & Hepatology

Diagnosis and Management of Primary Sclerosing Cholangitis

Roger Chapman et al.

HEPATOLOGY (2010)

Article Gastroenterology & Hepatology

Hilar cholangiocarcinoma: the Memorial Sloan-Kettering Cancer Center experience

Flavio G. Rocha et al.

JOURNAL OF HEPATO-BILIARY-PANCREATIC SCIENCES (2010)

Review Gastroenterology & Hepatology

Radical surgery for right-sided klatskin tumor

P. Neuhaus et al.

Review Gastroenterology & Hepatology

Criteria of unresectability and the decision-making process

R. D. Schulick

Review Gastroenterology & Hepatology

Epidemiology, risk factors, and pathogenesis of cholangiocarcinoma

S. A. Khan et al.

Article Surgery

Liver resection in Veterans Affairs and selected university medical centers: Results of the Patient Safety in Surgery Study

Robert T. Lancaster et al.

JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS (2007)

Article Gastroenterology & Hepatology

Hilar cholangiocarcinoma: resectability and radicality after routine diagnostic imaging

G Otto et al.

JOURNAL OF HEPATO-BILIARY-PANCREATIC SURGERY (2004)

Article Surgery

Is extended hepatectomy for hepatobiliary malignancy justified?

JN Vauthey et al.

ANNALS OF SURGERY (2004)